PIK3CD and acute lymphoblastic leukemia: A recent preclinical study showed that, while p110δ is important for PTEN-deficient T-ALL, p110δ-specific inhibition was not sufficient to suppress tumorigenesis, thus combined inhibition of p110δ and p110γ is required to block T-ALL [7].